Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Cyted uses artificial intelligence (AI) and digital pathology to improve the detection and diagnosis of diseases, including cancer.
ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.
Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.
etherna develops mRNA and lipid nanoparticle solutions.
T-knife is a developer of T cell receptors intended for T cell therapy of cancer.
Visus Therapeutics is a clinical-stage company developing innovative medicines.
Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.
Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.
AviadoBio transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.
Neurent Medical is a medical device startup that develops non-surgical treatments for inflammatory sino-nasal diseases.
Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.
SNIPR Biome is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases.
Neuros Medical develops neurostimulation therapies for patients suffering with unmet medical needs.
Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.
Avidicure is pioneering an entirely new dual agonistic, multifunctional and avidity engineered antibody modality.
Perfuze is a medical device company developing catheter-based aspiration technology to treat acute ischemic stroke.
VarmX B.V. is manufacturing therapeutic proteins to instantaneously restore blood clotting in bleeding patients.
XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.
NUA Surgical develops a specialised surgical retractor to make C-Sections a safer and superior surgery.
PanTera produces actinium-225 for personalized cancer treatment and radiopharmaceuticals.
EQT Life Sciences has invested in 81 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
EQT Life Sciences's top investment sectors include Health Care, Biotechnology, Therapeutics, Pharmaceutical, Medical Device. The firm invests across 17 different industry categories.
Among tracked funding rounds, Tubulis received $400.6M in a Series C round. EQT Life Sciences's total known invested capital is $3.8B.
EQT Life Sciences's average investment size is $61.0M across its portfolio of 81 companies.
Recent EQT Life Sciences portfolio additions include Cyted, ImCheck Therapeutics, Cardior Pharmaceuticals, etherna immunotherapies, T-knife. These companies were founded in 2020 or later.